Merck and Otsuka recognized for driving greater equality for women in the workplace.
With gender inequality a continued area of focus for corporations and workplaces around the globe, the Healthcare Businesswomen’s Association (HBA) is proud to recognize Merck & Co., Inc. and Otsuka America Pharmaceutical, Inc. for exemplary workplace initiatives working to close the gender gap in the healthcare and life science industries. The awards will be presented on Wednesday, 10 November, in conjunction with HBA’s virtual Annual Conference.
HBA’s Advancement. Commitment. Engagement. (ACE) Awards recognize companies committed to ensuring that gender diversity and leadership opportunities for women are part of their organizational DNA. An independent panel of healthcare industry leaders selects ACE Award recipients for their excellence in advancing their female talent and removing the systemic barriers preventing timely progress to parity. Award criteria include measurable results, business performance, stewardship, execution, and sustainability.
With a 26-year history, Merck’s Women’s Network validates the organization’s long-term commitment to diversity and inclusion and demonstrates how integral these values are to achieving better healthcare outcomes for the patients they serve. With 10,000 women participating, there are a variety of initiatives supporting the drive to greater equality including a Gender Equality Council, Mentoring Programs, a Women’s Network European Personal Branding Program, and an Executive Speaker Series.
Otsuka’s Network of Otsuka Women (NOW) has delivered impressive influence and impact in a short time since it was founded in 2019. Sponsorship by the company’s CEO and CCO, and support from the board, speak to Otsuka’s commitment to including diversity, equity, and inclusion as key imperatives as part of its global business strategy.
Read more about the winners here.
The Weight-Loss Gold Rush: Legal and Regulatory Implications
July 11th 2024Jim Shehan, chair of the FDA Regulatory practice, Lowenstein Sandler, discusses how the FDA and other regulators likely to respond to the increased public interest and potential off-label use of GLP-1 drugs, what needs to be done for GLP-1s to be covered, advice for investors and financiers considering entering the weight-loss medication market and more.
Healthcare Marketing Strategies for Reaching Diverse Audiences
May 14th 2024Amanda Powers-Han, Chief Marketing Officer, Greater Than One, and Pharmaceutical Executive Editorial Advisory Board member, discusses how improved DE&I in healthcare marketing strategies can not only reach diverse audiences more effectively but also contribute to improved patient care outcomes, challenges faced in crafting culturally sensitive messages, and much more.